Decitabine and Cisplatin are Synergistic to Exert Anti-Tumor Effect on Gastric Cancer via Inducing Sox2 DNA Demethylation

References

• Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev. 2014;23(5):700–713. doi:10.1158/1055-9965.EPI-13-1057
   PubMed Web of Science ®Google Scholar
• Ajani JA, Lee J, Sano T, Janjigian YY, Fan D, Song S. Gastric adenocarcinoma. Nat Rev Dis Primers. 2017;3(1):17036. doi:10.1038/nrdp.2017.36
   PubMedGoogle Scholar
• Toiyama Y, Okugawa Y, Goel A. DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer. Biochem Biophys Res Commun. 2014;455(1–2):43–57. doi:10.1016/j.bbrc.2014.08.001
   PubMed Web of Science ®Google Scholar
• Li L, Ying J, Li H, et al. The human cadherin 11 is a pro-apoptotic tumor suppressor modulating cell stemness through Wnt/beta-catenin signaling and silenced in common carcinomas. Oncogene. 2012;31(34):3901–3912. doi:10.1038/onc.2011.541
   PubMed Web of Science ®Google Scholar
• Esteller M, Fraga MF, Guo M, et al. DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. Hum Mol Genet. 2001;10(26):3001–3007. doi:10.1093/hmg/10.26.3001
   PubMed Web of Science ®Google Scholar
• Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation profile of human cancer. Cancer Res. 2001;61(8):3225–3229.
   PubMed Web of Science ®Google Scholar
• Tsukamoto T, Inada K, Tanaka H, et al. Down-regulation of a gastric transcription factor, Sox2, and ectopic expression of intestinal homeobox genes, Cdx1 and Cdx2: inverse correlation during progression from gastric/intestinal-mixed to complete intestinal metaplasia. J Cancer Res Clin Oncol. 2004;130(3):135–145. doi:10.1007/s00432-003-0519-6
   PubMed Web of Science ®Google Scholar
• Tsukamoto T, Mizoshita T, Mihara M, et al. Sox2 expression in human stomach adenocarcinomas with gastric and gastric-and-intestinal-mixed phenotypes. Histopathology. 2005;46(6):649–658. doi:10.1111/j.1365-2559.2005.02170.x
   PubMed Web of Science ®Google Scholar
• Hutz K, Mejias-Luque R, Farsakova K, et al. The stem cell factor SOX2 regulates the tumorigenic potential in human gastric cancer cells. Carcinogenesis. 2014;35(4):942–950. doi:10.1093/carcin/bgt410
   PubMed Web of Science ®Google Scholar
• Tian T, Zhang Y, Wang S, Zhou J, Xu S. Sox2 enhances the tumorigenicity and chemoresistance of cancer stem-like cells derived from gastric cancer. J Biomed Res. 2012;26(5):336–345. doi:10.7555/JBR.26.20120045
   PubMedGoogle Scholar
• Matsuoka J, Yashiro M, Sakurai K, et al. Role of the stemness factors sox2, oct3/4, and nanog in gastric carcinoma. J Surg Res. 2012;174(1):130–135. doi:10.1016/j.jss.2010.11.903
   PubMed Web of Science ®Google Scholar
• Li XL, Eishi Y, Bai YQ, et al. Expression of the SRY-related HMG box protein SOX2 in human gastric carcinoma. Int J Oncol. 2004;24(2):257–263.
   PubMed Web of Science ®Google Scholar
• Otsubo T, Akiyama Y, Yanagihara K, Yuasa Y. SOX2 is frequently downregulated in gastric cancers and inhibits cell growth through cell-cycle arrest and apoptosis. Br J Cancer. 2008;98(4):824–831. doi:10.1038/sj.bjc.6604193
   PubMed Web of Science ®Google Scholar
• Otsubo T, Akiyama Y, Hashimoto Y, Shimada S, Goto K, Yuasa Y. MicroRNA-126 inhibits SOX2 expression and contributes to gastric carcinogenesis. PLoS One. 2011;6(1):e16617. doi:10.1371/journal.pone.0016617
   PubMed Web of Science ®Google Scholar
• Camilo V, Barros R, Sousa S, et al. Helicobacter pylori and the BMP pathway regulate CDX2 and SOX2 expression in gastric cells. Carcinogenesis. 2012;33(10):1985–1992. doi:10.1093/carcin/bgs233
   PubMed Web of Science ®Google Scholar
• Zhang X, Yu H, Yang Y, et al. SOX2 in gastric carcinoma, but not Hath1, is related to patients’ clinicopathological features and prognosis. J Gastrointest Surg. 2010;14(8):1220–1226. doi:10.1007/s11605-010-1246-3
   PubMed Web of Science ®Google Scholar
• Wang S, Tie J, Wang R, et al. SOX2, a predictor of survival in gastric cancer, inhibits cell proliferation and metastasis by regulating PTEN. Cancer Lett. 2015;358(2):210–219. doi:10.1016/j.canlet.2014.12.045
   PubMed Web of Science ®Google Scholar
• Sartorius UA, Krammer PH. Upregulation of Bcl-2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell lines. Int J Cancer. 2002;97(5):584–592. doi:10.1002/ijc.10096
   PubMed Web of Science ®Google Scholar
• Helmbach H, Kern MA, Rossmann E, et al. Drug resistance towards etoposide and cisplatin in human melanoma cells is associated with drug-dependent apoptosis deficiency. J Invest Dermatol. 2002;118(6):923–932. doi:10.1046/j.1523-1747.2002.01786.x
   PubMed Web of Science ®Google Scholar
• Sussman RT, Stanek TJ, Esteso P, Gearhart JD, Knudsen KE, McMahon SB. The epigenetic modifier ubiquitin-specific protease 22 (USP22) regulates embryonic stem cell differentiation via transcriptional repression of sex-determining region Y-box 2 (SOX2). J Biol Chem. 2013;288(33):24234–24246. doi:10.1074/jbc.M113.469783
   PubMed Web of Science ®Google Scholar
• Momparler RL. Epigenetic therapy of non-small cell lung cancer using decitabine (5-aza-2ʹ-deoxycytidine). Front Oncol. 2013;3:188. doi:10.3389/fonc.2013.00188
   PubMedGoogle Scholar
• Albertus DL, Seder CW, Chen G, et al. AZGP1 autoantibody predicts survival and histone deacetylase inhibitors increase expression in lung adenocarcinoma. J Thorac Oncol. 2008;3(11):1236–1244. doi:10.1097/JTO.0b013e318189f5ec
   PubMed Web of Science ®Google Scholar
• Gravina GL, Marampon F, Di Staso M, et al. 5-Azacitidine restores and amplifies the bicalutamide response on preclinical models of androgen receptor expressing or deficient prostate tumors. Prostate. 2010;70(11):1166–1178. doi:10.1002/pros.21151
   PubMed Web of Science ®Google Scholar
• Viet CT, Dang D, Achdjian S, Ye Y, Katz SG, Schmidt BL. Decitabine rescues cisplatin resistance in head and neck squamous cell carcinoma. PLoS One. 2014;9(11):e112880. doi:10.1371/journal.pone.0112880
   PubMed Web of Science ®Google Scholar
• Balch C, Yan P, Craft T, et al. Antimitogenic and chemosensitizing effects of the methylation inhibitor zebularine in ovarian cancer. Mol Cancer Ther. 2005;4(10):1505–1514. doi:10.1158/1535-7163.MCT-05-0216
   PubMed Web of Science ®Google Scholar
• Momparler RL. Cancer epigenetics. Oncogene. 2003;22(42):6479–6483. doi:10.1038/sj.onc.1206774
   PubMed Web of Science ®Google Scholar
• Wei Z, Yang Y, Zhang P, et al. Klf4 interacts directly with Oct4 and Sox2 to promote reprogramming. Stem Cells. 2009;27(12):2969–2978. doi:10.1002/stem.231
   PubMed Web of Science ®Google Scholar
• van den Berg DL, Snoek T, Mullin NP, et al. An Oct4-centered protein interaction network in embryonic stem cells. Stem Cell. 2010;6(4):369–381. doi:10.1016/j.stem.2010.02.014
   Google Scholar
• Driessens G, Blanpain C. Long live sox2: sox2 lasts a lifetime. Stem Cell. 2011;9(4):283–284. doi:10.1016/j.stem.2011.09.007
   Google Scholar
• Masui S, Nakatake Y, Toyooka Y, et al. Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat Cell Biol. 2007;9(6):625–635. doi:10.1038/ncb1589
   PubMed Web of Science ®Google Scholar
• Avilion AA, Nicolis SK, Pevny LH, Perez L, Vivian N, Lovell-Badge R. Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev. 2003;17(1):126–140. doi:10.1101/gad.224503
   PubMed Web of Science ®Google Scholar
• Wang SQ, Liu J, Qin J, et al. CAMK2A supported tumor initiating cells of lung adenocarcinoma by upregulating SOX2 through EZH2 phosphorylation. Cell Death Dis. 2020;11(6):410. doi:10.1038/s41419-020-2553-6
   PubMed Web of Science ®Google Scholar
• Rybak AP, Tang D. SOX2 plays a critical role in EGFR-mediated self-renewal of human prostate cancer stem-like cells. Cell Signal. 2013;25(12):2734–2742. doi:10.1016/j.cellsig.2013.08.041
   PubMed Web of Science ®Google Scholar
• Xianglong Tian JZ, Biao L. T-cadherin expression induced by 5-azo-2 ‘-deoxycytidine in nude mouse HepG2 tumor cells and its inhibitory effect on tumor growth. J Shanghai Jiao Tong Univ. 2007;27(5):533–536.
   Google Scholar
• Zhilun Liang ZH, Chen X. T-cadherin expression induced by 5-azo-2 ‘-deoxycytidine in nude mouse HepG2 tumor cells and its inhibitory effect on tumor growth. World Chin Dig J. 2008;16(16):1741–1745. doi:10.11569/wcjd.v16.i16.1741
   Google Scholar
• Plumb JA, Strathdee G, Sludden J, Kaye SB, Brown R. Reversal of drug resistance in human tumor xenografts by 2ʹ-deoxy-5-azacytidine-induced demethylation of the hMLH1 gene promoter. Cancer Res. 2000;60(21):6039–6044.
   PubMed Web of Science ®Google Scholar